ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0963

Chronic Obstructive Pulmonary Disease Associated with Prolonged Opiate Use, Increased Short-Term Complications and the Need for Revision Surgery Following Total Knee Arthroplasty

Jillian Glasser1, Nicholas Lemme2, Daniel Yang2, Edward Testa2, Alan Daniels3 and Valentin Antoci3, 1University Orthopedics Inc, East Providence, RI, 2Warren Alpert School of Medicine, Providence, RI, 3Warren Alpert School of Medicine, East Providence, RI

Meeting: ACR Convergence 2020

Keywords: Arthritis, Infectious, Arthroplasty, Comorbidity, Osteoarthritis, Prosthetic Joint

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Orthopedics, Low Back Pain, & Rehabilitation (0960–0964)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Chronic obstructive pulmonary disease (COPD) is a condition which causes a substantial burden to patients, physicians, and the healthcare system at large. Medical comorbidities are commonly associated with adverse health outcomes in the postoperative period. Here, we present a large database review of patients undergoing total knee arthroplasty (TKA) to determine the effect of COPD on patient outcomes.

Methods: The PearlDiver database was queried for all patients who underwent TKA between 2007 and the first quarter of 2017.  Medical complications, surgical complications, 30-day readmission rates, revision rates, and opioid utilization were assessed at various intervals following TKA.

Results: 46,769 TKA patients with COPD and 120,177 TKA patients without COPD were studied. TKA patients with COPD experienced increased risk of 30-day readmission (40.8% vs. 32.2%, p< 0.0001), 30-day total medical complications (10.2% vs. 7.0%, p< 0.0001), prosthesis explanation at 6 months (0.4% vs. 0.2, p=0.0130), 1 year (0.6% vs. 0.3%, p=0.0005), and 2 years (0.8% vs. 0.5%, p=0.0003), as well as an increased rate of revision (p< 0.0046) compared to TKA patients without COPD. Opioid utilization of TKA patients with COPD was greater than that of TKA patients without COPD at 3,16 and 12 months.

Conclusion: Patients with COPD have an increased risk for medical and surgical complications, readmission, and prolonged opioid use following TKA. Patients undergoing TKA with a history of COPD represent a high-risk patient population, and it is prudent to ensure that such patients are fully optimized in the perioperative period to reduce complications and minimize health-care costs.


Disclosure: J. Glasser, None; N. Lemme, None; D. Yang, None; E. Testa, None; A. Daniels, None; V. Antoci, None.

To cite this abstract in AMA style:

Glasser J, Lemme N, Yang D, Testa E, Daniels A, Antoci V. Chronic Obstructive Pulmonary Disease Associated with Prolonged Opiate Use, Increased Short-Term Complications and the Need for Revision Surgery Following Total Knee Arthroplasty [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/chronic-obstructive-pulmonary-disease-associated-with-prolonged-opiate-use-increased-short-term-complications-and-the-need-for-revision-surgery-following-total-knee-arthroplasty/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chronic-obstructive-pulmonary-disease-associated-with-prolonged-opiate-use-increased-short-term-complications-and-the-need-for-revision-surgery-following-total-knee-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology